For: | Azevedo A, Cunha V, Teixeira AL, Medeiros R. IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol 2011; 2(12): 384-396 [PMID: 22171281 DOI: 10.5306/wjco.v2.i12.384] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v2/i12/384.htm |
Number | Citing Articles |
1 |
Bilal Bin Hafeez, Joseph W. Fischer, Ashok Singh, Weixiong Zhong, Ala Mustafa, Louise Meske, Mohammad Ozair Sheikhani, Ajit Kumar Verma. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCϵ, Stat3, and Epithelial-to-Mesenchymal Transition Markers. Cancer Prevention Research 2015; 8(5): 375 doi: 10.1158/1940-6207.CAPR-14-0231
|
2 |
Amitabh Kumar Upadhyay, Manoj Kumar, Abhishek Kumar, Anil Prasad, Aaditya Prakash. Association Between Synchronous Occurrence of Multiple Myeloma and Carcinoma Prostate: Literature Analysis in the Context of a Case Report. Cureus 2023; doi: 10.7759/cureus.48523
|
3 |
Pavel Sluka, Ian D. Davis. Cell mates: paracrine and stromal targets for prostate cancer therapy. Nature Reviews Urology 2013; 10(8): 441 doi: 10.1038/nrurol.2013.146
|
4 |
Shengquan Huang, Qian Liu, Qianjin Liao, Qingjian Wu, Bishao Sun, Zhenxing Yang, Xiaoyan Hu, Mingjia Tan, Longkun Li. Interleukin‐6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression. Cancer Science 2018; 109(3): 678 doi: 10.1111/cas.13493
|
5 |
Rachel A. Sabol, Paulina Giacomelli, Adam Beighley, Bruce A. Bunnell. Adipose Stem Cells and Cancer: Concise Review. Stem Cells 2019; 37(10): 1261 doi: 10.1002/stem.3050
|
6 |
Jingjing Li, Tianjie Pu, Lijuan Yin, Qinlong Li, Chun-Peng Liao, Boyang Jason Wu. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness. Oncogene 2020; 39(16): 3305 doi: 10.1038/s41388-020-1217-4
|
7 |
Katie Joanna Miller, Mohammad Asim. Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer. Cells 2022; 11(6): 952 doi: 10.3390/cells11060952
|
8 |
Wenqiang Zhang, Qiwei Nie, Xuling Zhang, Long Huang, Guofu Pang, Jing Chu, Xiaoxu Yuan.
miR-26a-5p restoration
via
EZH2 silencing blocks the IL-6/STAT3 axis to repress the growth of prostate cancer
. Expert Opinion on Therapeutic Targets 2023; 27(12): 1285 doi: 10.1080/14728222.2023.2293750
|
9 |
Dinesh K. R. Medipally, Daniel Cullen, Valérie Untereiner, Ganesh D. Sockalingum, Adrian Maguire, Thi Nguyet Que Nguyen, Jane Bryant, Emma Noone, Shirley Bradshaw, Marie Finn, Mary Dunne, Aoife M. Shannon, John Armstrong, Aidan D. Meade, Fiona M Lyng. Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920918499
|
10 |
Philippe Pérot, Michaël Falguieres, Laurence Arowas, Hélène Laude, Jean-Philippe Foy, Patrick Goudot, Nicole Corre-Catelin, Marie-Noëlle Ungeheuer, Valérie Caro, Isabelle Heard, Marc Eloit, Antoine Gessain, Chloé Bertolus, Nicolas Berthet, Muy-Teck Teh. Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients. PLOS ONE 2020; 15(4): e0232138 doi: 10.1371/journal.pone.0232138
|
11 |
Mariana Cárdenas-González, Octavio Gaspar-Ramírez, Francisco J. Pérez-Vázquez, Jorge Alejandro Alegría-Torres, Roberto González-Amaro, Iván N. Pérez-Maldonado. p,p′-DDE, a DDT metabolite, induces proinflammatory molecules in human peripheral blood mononuclear cells “in vitro”. Experimental and Toxicologic Pathology 2013; 65(5): 661 doi: 10.1016/j.etp.2012.07.006
|
12 |
Brij K. Gupta, Diane M. Maher, Mara C. Ebeling, Phillip D. Stephenson, Susan E. Puumala, Michael R. Koch, Hiroyuki Aburatani, Meena Jaggi, Subhash C. Chauhan. Functions and regulation of MUC13 mucin in colon cancer cells. Journal of Gastroenterology 2014; 49(10): 1378 doi: 10.1007/s00535-013-0885-z
|
13 |
Manja Idorn, Tania Køllgaard, Per Kongsted, Lisa Sengeløv, Per thor Straten. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer. Cancer Immunology, Immunotherapy 2014; 63(11): 1177 doi: 10.1007/s00262-014-1591-2
|
14 |
Yaroslava Karpova, Sarah J. Johnson, Guillaume Bordet, Danping Guo, Atreyi Ghatak, Dmitriy A. Markov, Alexei V. Tulin. Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes. Biomedicine & Pharmacotherapy 2022; 153: 113504 doi: 10.1016/j.biopha.2022.113504
|
15 |
Tandrima Mitra, Monica Prusty, Selvakumar Elangovan. Identification and validation of miR-21 key genes in cervical cancer through an integrated bioinformatics approach. Computational Biology and Chemistry 2024; 113: 108280 doi: 10.1016/j.compbiolchem.2024.108280
|
16 |
Piotr Bialas, Tamae Kobayashi, Rebecka Hellsten, Agnieszka Krzyzanowska, Margareta Persson, Felicia Marginean, Dominique Trudel, Isla P. Garraway, Bruce J. Trock, Pekka Taimen, Fred Saad, Tuomas Mirtti, Beatrice Knudsen, Angelo M. De Marzo, Anders Bjartell. pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy. The Prostate 2024; doi: 10.1002/pros.24820
|
17 |
Maria Teresa Palano, Matteo Gallazzi, Martina Cucchiara, Federico Dehò, Paolo Capogrosso, Antonino Bruno, Lorenzo Mortara. The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors. Exploration of Targeted Anti-tumor Therapy 2022; : 694 doi: 10.37349/etat.2022.00108
|
18 |
Fang Xie, Jialu Xu, Lina Yan, Xia Xiao, Liang Liu. The AC010247.2/miR-125b-5p axis triggers the malignant progression of acute myelocytic leukemia by IL-6R. Heliyon 2024; 10(18): e37715 doi: 10.1016/j.heliyon.2024.e37715
|
19 |
Tania Valencia, Ji Young Kim, Shadi Abu-Baker, Jorge Moscat-Pardos, Christopher S. Ahn, Miguel Reina-Campos, Angeles Duran, Elias A. Castilla, Christian M. Metallo, Maria T. Diaz-Meco, Jorge Moscat. Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis. Cancer Cell 2014; 26(1): 121 doi: 10.1016/j.ccr.2014.05.004
|
20 |
Hua Xu, Meng-bo Hu, Pei-de Bai, Wen-hui Zhu, Sheng-hua Liu, Jun-yao Hou, Zu-quan Xiong, Qiang Ding, Hao-wen Jiang. Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/249741
|
21 |
Meenakshi Meenu, Vipin Kumar Verma, Amlesh Seth, Ranjit Kumar Sahoo, Pooja Gupta, Dharamvir Singh Arya. Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer. Current Therapeutic Research 2020; 93: 100610 doi: 10.1016/j.curtheres.2020.100610
|
22 |
Reshu Tewari, Singh Rajender, S.M. Natu, Apul Goel, Divakar Dalela, M.M. Goel, Pushpa Tondon. Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men – A cross-sectional study. Cytokine 2013; 63(2): 130 doi: 10.1016/j.cyto.2013.04.008
|
23 |
Hugo-Henrique SILVA, Maria-Raquel G. SILVA, Fátima CERQUEIRA, Valéria TAVARES, Rui MEDEIROS. Genomic profile in association with sport-type, sex, ethnicity, psychological traits and sport injuries of elite athletes. The Journal of Sports Medicine and Physical Fitness 2022; 62(3) doi: 10.23736/S0022-4707.21.12020-1
|
24 |
Asma’a H. Mohamed, Abdulrahman T. Ahmed, Waleed Al Abdulmonem, Dmitry Olegovich Bokov, Alaa Shafie, Hussein Riyadh Abdul Kareem Al-Hetty, Chou-Yi Hsu, Mohammed Alissa, Shahid Nazir, Mohammad Chand Jamali, Mustafa Mudhafar. Interleukin-6 serves as a critical factor in various cancer progression and therapy. Medical Oncology 2024; 41(7) doi: 10.1007/s12032-024-02422-5
|
25 |
Ryan M. Samuel, Homa Majd, Mikayla N. Richter, Zaniar Ghazizadeh, Seyedeh Maryam Zekavat, Albertas Navickas, Jonathan T. Ramirez, Hosseinali Asgharian, Camille R. Simoneau, Luke R. Bonser, Kyung Duk Koh, Miguel Garcia-Knight, Michel Tassetto, Sara Sunshine, Sina Farahvashi, Ali Kalantari, Wei Liu, Raul Andino, Hongyu Zhao, Pradeep Natarajan, David J. Erle, Melanie Ott, Hani Goodarzi, Faranak Fattahi. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Cell Stem Cell 2020; 27(6): 876 doi: 10.1016/j.stem.2020.11.009
|
26 |
Runan Qin, Yue Wang, Shengyuan Wang, Bing Xia, Rui Xin, Chang Li, Yonghui Wu. Nickel-refining dust regulates the expression of inflammatory factors in NIH/3T3 cells. Toxicology and Industrial Health 2019; 35(3): 239 doi: 10.1177/0748233719828589
|
27 |
Lina Abdelghany, Xu Zhang, Tsuyoshi Kawabata, Shinji Goto, Nageh El-Mahdy, Keiichi Jingu, Tao-Sheng Li. Nicaraven prevents the fast growth of inflamed tumors by an anti-inflammatory mechanism. Medical Oncology 2022; 39(1) doi: 10.1007/s12032-021-01602-x
|
28 |
Yuanyuan Xu, Erik J. Tokar, Yang Sun, Michael P. Waalkes. Arsenic-Transformed Malignant Prostate Epithelia Can Convert Noncontiguous Normal Stem Cells into an Oncogenic Phenotype. Environmental Health Perspectives 2012; 120(6): 865 doi: 10.1289/ehp.1204987
|
29 |
Olga Golubnitschaja, Krishna Chander Sridhar. Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clinical & Experimental Metastasis 2016; 33(8): 743 doi: 10.1007/s10585-016-9816-8
|
30 |
Dorothea Dietrichs, Daniela Grimm, Jayashree Sahana, Daniela Melnik, Thomas J. Corydon, Markus Wehland, Marcus Krüger, Randy Vermeesen, Bjorn Baselet, Sarah Baatout, Trine Engelbrecht Hybel, Stefan Kahlert, Herbert Schulz, Manfred Infanger, Sascha Kopp. Three-Dimensional Growth of Prostate Cancer Cells Exposed to Simulated Microgravity. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.841017
|
31 |
Victor J. B. van Santen, Behrouz Zandieh Doulabi, Cornelis M. Semeins, Jolanda M. A. Hogervorst, Cornelia Bratengeier, Astrid D. Bakker. Compressed Prostate Cancer Cells Decrease Osteoclast Activity While Enhancing Osteoblast Activity In Vitro. International Journal of Molecular Sciences 2023; 24(1): 759 doi: 10.3390/ijms24010759
|
32 |
Qiang Zhang, Li-Jiang Sun, Jun Qi, Zhi-Gang Yang, Tao Huang. Influence of Adipocytokines and Periprostatic Adiposity Measurement Parameters on Prostate Cancer Aggressiveness. Asian Pacific Journal of Cancer Prevention 2014; 15(4): 1879 doi: 10.7314/APJCP.2014.15.4.1879
|
33 |
Jing-Wen Shih, Ling-Yu Wang, Chiu-Lien Hung, Hsing-Jien Kung, Chia-Ling Hsieh. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism. International Journal of Molecular Sciences 2015; 16(12): 28943 doi: 10.3390/ijms161226138
|
34 |
Luigi Racioppi. CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem. Trends in Molecular Medicine 2013; 19(2): 83 doi: 10.1016/j.molmed.2012.12.004
|
35 |
Jungsug Gwak, Hayan Jeong, Kwanghyun Lee, Jee Yoon Shin, Taejun Sim, Jungtae Na, Jongchan Kim, Bong-Gun Ju. SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer. Cancers 2020; 12(9): 2718 doi: 10.3390/cancers12092718
|
36 |
Armando Olivas, Ramona Salcedo Price. Obesity, Inflammation, and Advanced Prostate Cancer. Nutrition and Cancer 2021; 73(11-12): 2232 doi: 10.1080/01635581.2020.1856889
|
37 |
Michael Melnick, Parish P Sedghizadeh, Krysta A Deluca, Tina Jaskoll. Cytomegalovirus-induced salivary gland pathology: resistance to kinase inhibitors of the upregulated host cell EGFR/ERK pathway is associated with CMV-dependent stromal overexpression of IL-6 and fibronectin. Herpesviridae 2013; 4(1) doi: 10.1186/2042-4280-4-1
|
38 |
Catherine Muller, Laurence Nieto, Philippe Valet. Adipose Tissue and Cancer. 2013; : 121 doi: 10.1007/978-1-4614-7660-3_7
|
39 |
Lin Shi, Lingyan Wang, Jiayan Hou, Bijun Zhu, Zhihui Min, Miaomiao Zhang, Dongli Song, Yunfeng Cheng, Xiangdong Wang. Targeting roles of inflammatory microenvironment in lung cancer and metastasis. Cancer and Metastasis Reviews 2015; 34(2): 319 doi: 10.1007/s10555-015-9570-4
|
40 |
Ji-Long Zhou, Zhen Ding, Xing Ge, Qiao-Mei Shi, Heng-Xue Wang, Gang Chen, Meng-Xue Li, Hui Wang, Qiang Ju, Qi Wang, Jin-Peng Zhang, Mei-Rong Zhang, Li-Chun Xu. Cypermethrin inhibits interleukin-6-induced androgen receptor transactivation through signal transducer and activator of transcription 3. Toxicology Mechanisms and Methods 2017; 27(9): 717 doi: 10.1080/15376516.2017.1351505
|
41 |
Mónica Gomes, Ana Coelho, António Araújo, Andreia Azevedo, Ana Luísa Teixeira, Raquel Catarino, Rui Medeiros. IL-6 polymorphism in non-small cell lung cancer: a prognostic value?. Tumor Biology 2015; 36(5): 3679 doi: 10.1007/s13277-014-3006-6
|
42 |
Sang-Su Kim, Kyu-Shik Kim, Ik-Hwan Han, Yeseul Kim, Seong Sik Bang, Jung-Hyun Kim, Yong-Suk Kim, Soo-Yeon Choi, Jae-Sook Ryu. Proliferation of Mouse Prostate Cancer Cells Inflamed by Trichomonas vaginalis. The Korean Journal of Parasitology 2021; 59(6): 547 doi: 10.3347/kjp.2021.59.6.547
|
43 |
Kristo Ausmees, Paul Korrovits, Gennadi Timberg, Margus Punab, Reet Mändar. Semen quality and associated reproductive indicators in middle-aged males: the role of non-malignant prostate conditions and genital tract inflammation. World Journal of Urology 2013; 31(6): 1411 doi: 10.1007/s00345-013-1078-3
|
44 |
Qiang Zhang, Li-jiang Sun, Zhi-gang Yang, Gui-ming Zhang, Ri-cha Huo. Influence of adipocytokines in periprostatic adipose tissue on prostate cancer aggressiveness. Cytokine 2016; 85: 148 doi: 10.1016/j.cyto.2016.06.019
|
45 |
Muzamil Y Want, Takemasa Tsuji, Prashant K Singh, James L Thorne, Junko Matsuzaki, Ellen Karasik, Bryan Gillard, Eduardo Cortes Gomez, Richard C. Koya, Amit Lugade, Kunle Odunsi, Sebastiano Battaglia. WHSC1/NSD2 regulates immune infiltration in prostate cancer. Journal for ImmunoTherapy of Cancer 2021; 9(2): e001374 doi: 10.1136/jitc-2020-001374
|
46 |
X Lu, H An, R Jin, M Zou, Y Guo, P-F Su, D Liu, Y Shyr, W G Yarbrough. PPM1A is a RelA phosphatase with tumor suppressor-like activity. Oncogene 2014; 33(22): 2918 doi: 10.1038/onc.2013.246
|
47 |
DING MA, ZHE ZHOU, BING YANG, QUN HE, QIAN ZHANG, XIANG-HUA ZHANG. Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining. Oncology Letters 2015; 10(4): 2185 doi: 10.3892/ol.2015.3556
|
48 |
Siti Hasyimah Suhaimi, Rosnani Hasham, Mohamad Khairul Hafiz Idris, Hassan Fahmi Ismail, Nor Hazwani Mohd Ariffin, Fadzilah Adibah Abdul Majid. Optimization of Ultrasound-Assisted Extraction Conditions Followed by Solid Phase Extraction Fractionation from Orthosiphon stamineus Benth (Lamiace) Leaves for Antiproliferative Effect on Prostate Cancer Cells. Molecules 2019; 24(22): 4183 doi: 10.3390/molecules24224183
|
49 |
Isaac J. Powell, Sreenivasa R. Chinni, Sunil S. Reddy, Alexander Zaslavsky, Navnath Gavande. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update. Urologic Oncology: Seminars and Original Investigations 2021; 39(1): 34 doi: 10.1016/j.urolonc.2020.08.019
|
50 |
Emma H. Allott, Elizabeth M. Masko, Stephen J. Freedland. Obesity and Prostate Cancer: Weighing the Evidence. European Urology 2013; 63(5): 800 doi: 10.1016/j.eururo.2012.11.013
|
51 |
Hui-Ming Lin, Nicole Yeung, Jordan F. Hastings, David R. Croucher, Kevin Huynh, Thomas G. Meikle, Natalie A. Mellett, Edmond M. Kwan, Ian D. Davis, Ben Tran, Kate L. Mahon, Alison Zhang, Martin R. Stockler, Karen Briscoe, Gavin Marx, Patricia Bastick, Megan L. Crumbaker, Anthony M. Joshua, Arun A. Azad, Peter J. Meikle, Lisa G. Horvath. Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer. Cancers 2021; 13(19): 4964 doi: 10.3390/cancers13194964
|
52 |
Faris Azzouni, James Mohler. Biology of Castration-Recurrent Prostate Cancer. Urologic Clinics of North America 2012; 39(4): 435 doi: 10.1016/j.ucl.2012.07.002
|
53 |
Emily J. Gallagher, Derek LeRoith. Epidemiology and Molecular Mechanisms Tying Obesity, Diabetes, and the Metabolic Syndrome With Cancer. Diabetes Care 2013; 36(Supplement_2): S233 doi: 10.2337/dcS13-2001
|
54 |
Ankit Kumar Singh, Ratnakar Tiwari, Vijay Kumar, Prabhakar Singh, S.K. Riyazat Khadim, Anupam Tiwari, Vikas Srivastava, S.H. Hasan, R.K. Asthana. Photo-induced biosynthesis of silver nanoparticles from aqueous extract of Dunaliella salina and their anticancer potential. Journal of Photochemistry and Photobiology B: Biology 2017; 166: 202 doi: 10.1016/j.jphotobiol.2016.11.020
|
55 |
J. Morote, A. Celma, J. Planas, J. Placer, C. Konstantinidis, I. Iztueta, I.M. de Torres, M. Oliván, J. Reventós, A. Doll. Sedentarismo y sobrepeso como factores de riesgo en la detección del cáncer de próstata y su agresividad. Actas Urológicas Españolas 2014; 38(4): 232 doi: 10.1016/j.acuro.2013.09.001
|
56 |
Michael Melnick, Krysta A. Deluca, Parish P. Sedghizadeh, Tina Jaskoll. Cytomegalovirus-induced salivary gland pathology: AREG, FGF8, TNF-α, and IL-6 signal dysregulation and neoplasia. Experimental and Molecular Pathology 2013; 94(2): 386 doi: 10.1016/j.yexmp.2013.01.005
|
57 |
Fiona M. Frame, Norman J. Maitland. Stem Cells and Prostate Cancer. 2013; : 51 doi: 10.1007/978-1-4614-6498-3_4
|
58 |
Bertha Alicia Barajas-Gómez, Oscar Rosas-Carrasco, Sandra Lisbeth Morales-Rosales, Gibrán Pedraza Vázquez, Viridiana Yazmín González-Puertos, Teresa Juárez-Cedillo, Jorge Antonio García-Álvarez, Norma Edith López-Diazguerrero, Pablo Damián-Matsumura, Mina Königsberg, Armando Luna-López. Relationship of inflammatory profile of elderly patients serum and senescence-associated secretory phenotype with human breast cancer cells proliferation: Role of IL6/IL8 ratio. Cytokine 2017; 91: 13 doi: 10.1016/j.cyto.2016.12.001
|
59 |
Mai Ly Thi Nguyen, Khac Cuong Bui, Tim Scholta, Jun Xing, Vikas Bhuria, Bence Sipos, Ludwig Wilkens, Toan Nguyen Linh, Thirumalaisamy P Velavan, Przemyslaw Bozko, Ruben R Plentz. Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2021; 36(5): 1334 doi: 10.1111/jgh.15307
|
60 |
Cosmin-Victor Ene, Ilinca Nicolae, Bogdan Geavlete, Petrisor Geavlete, Corina Daniela Ene, Yun Ping Lim. IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis. Analytical Cellular Pathology 2022; 2022: 1 doi: 10.1155/2022/5980387
|
61 |
J. Morote, A. Celma, J. Planas, J. Placer, C. Konstantinidis, I. Iztueta, I.M. de Torres, M. Oliván, J. Reventós, A. Doll. Sedentarism and overweight as risk factors for the detection of prostate cancer and its aggressiveness. Actas Urológicas Españolas (English Edition) 2014; 38(4): 232 doi: 10.1016/j.acuroe.2013.12.003
|
62 |
Ik‐Hwan Han, Jung‐Hyun Kim, Ki‐Seok Jang, Jae‐Sook Ryu. Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells. The Prostate 2019; 79(10): 1133 doi: 10.1002/pros.23826
|
63 |
Xinyuan Lu, Wendell G. Yarbrough. Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer. Cytokine & Growth Factor Reviews 2015; 26(1): 7 doi: 10.1016/j.cytogfr.2014.09.003
|
64 |
Zhaoguo Liu, Cunsi Shen, Yu Tao, Siliang Wang, Zhonghong Wei, Yuzhu Cao, Hongyan Wu, Fangtian Fan, Chao Lin, Yunlong Shan, Pingting Zhu, Lihua Sun, Chen Chen, Aiyun Wang, Shizhong Zheng, Yin Lu. Chemopreventive efficacy of menthol on carcinogen-induced cutaneous carcinoma through inhibition of inflammation and oxidative stress in mice. Food and Chemical Toxicology 2015; 82: 12 doi: 10.1016/j.fct.2015.04.025
|
65 |
Mónica Gomes, Ana Luísa Teixeira, Ana Coelho, António Araújo, Rui Medeiros. Inflammation and Cancer. Advances in Experimental Medicine and Biology 2014; 816: 1 doi: 10.1007/978-3-0348-0837-8_1
|
66 |
A. Armakolas, A. Dimakakos, C. Loukogiannaki, N. Armakolas, A. Antonopoulos, C. Florou, P. Tsioli, E. Papageorgiou, T. P. Alexandrou, M. Stathaki, D. Spinos, D. Pektasides, E. Patsouris, M. Koutsilieris. IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumors. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0003-z
|
67 |
Thomas Edwards, Patricia Burke, Helen Smalley, Glyn Hobbs. Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis. Critical Reviews in Microbiology 2014; : 1 doi: 10.3109/1040841X.2014.958050
|
68 |
Shubham Goel, Smrity Sahu, Ranjana W. Minz, Surjit Singh, Deepti Suri, Young M. Oh, Amit Rawat, Shobha Sehgal, Biman Saikia. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01080
|
69 |
Jorge Blando, Achinto Saha, Kaoru Kiguchi, John DiGiovanni. Obesity, Inflammation and Cancer. 2013; : 235 doi: 10.1007/978-1-4614-6819-6_10
|
70 |
Dannah R Miller, Matthew A Ingersoll, Ming-Fong Lin. ErbB-2 signaling in advanced prostate cancer progression and potential therapy. Endocrine-Related Cancer 2019; 26(4): R195 doi: 10.1530/ERC-19-0009
|
71 |
Raavi Gupta, Maja Nowakowski, M. A. Haseeb. Infection and Cancer: Bi-Directorial Interactions. 2015; : 75 doi: 10.1007/978-3-319-20669-1_5
|
72 |
Fionnuala Crowley, Michelle Sterpi, Conor Buckley, Lauren Margetich, Shivani Handa, Zach Dovey. A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer. Research and Reports in Urology 2021; : 457 doi: 10.2147/RRU.S264722
|
73 |
Xiaolan LI, Songhua HE, Wei LIANG, Weiquan ZHANG, Xin CHEN, Qiaofeng LI, Xin YANG, Yanying LIU, Dan ZHU, Li LI, Buming LIU, Zhiheng SU, Jie CHEN, Hongwei GUO. Marsdenia tenacissima injection induces the apoptosis of prostate cancer by regulating the AKT/GSK3β/STAT3 signaling axis. Chinese Journal of Natural Medicines 2023; 21(2): 113 doi: 10.1016/S1875-5364(23)60389-9
|
74 |
Elizabeth A. Tindall, Gianluca Severi, Hoa N. Hoang, Melissa C. Southey, Dallas R. English, John L. Hopper, Graham G. Giles, Vanessa M. Hayes. Interleukin‐6 promoter variants, prostate cancer risk, and survival. The Prostate 2012; 72(16): 1701 doi: 10.1002/pros.22557
|
75 |
Steven M. Lucas, Elisabeth I. Heath. Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers. Prostate Cancer 2012; 2012: 1 doi: 10.1155/2012/640968
|
76 |
Lisa G. Lanigan, Blake E. Hildreth, Wessel P. Dirksen, Jessica K. Simmons, Chelsea K. Martin, Jillian L. Werbeck, Nandu K. Thudi, Tracey L. Papenfuss, Prosper N. Boyaka, Ramiro E. Toribio, Jerrold M. Ward, Katherine N. Weilbaecher, Thomas J. Rosol. In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene. The American Journal of Pathology 2021; 191(2): 335 doi: 10.1016/j.ajpath.2020.10.014
|
77 |
Qi Wang, Ji-Long Zhou, Hui Wang, Qiang Ju, Zhen Ding, Xiao-Long Zhou, Xing Ge, Qiao-Mei Shi, Chen Pan, Jin-Peng Zhang, Mei-Rong Zhang, Hong-Min Yu, Li-Chun Xu. Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation. Chemosphere 2016; 158: 24 doi: 10.1016/j.chemosphere.2016.05.053
|
78 |
Sara Cruciani, Donatella Coradduzza, Francesca Balzano, Giuseppe Garroni, Emanuela Azara, Renzo Pala, Alessandro P. Delitala, Massimo Madonia, Alessandro Tedde, Giampiero Capobianco, Marco Petrillo, Cecilia Angelucci, Ciriaco Carru, Carlo Ventura, Margherita Maioli. Modulation of adipose-derived stem cell behavior by prostate pathology-associated plasma: insights from in vitro exposure. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64625-0
|
79 |
M. Vogelhuber, S. Feyerabend, A. Stenzl, T. Suedhoff, M. Schulze, J. Huebner, R. Oberneder, W. Wieland, S. Mueller, F. Eichhorn, H. Heinzer, K. Schmidt, M. Baier, A. Ruebel, K. Birkholz, A. Bakhshandeh-Bath, R. Andreesen, A. Reichle. Evolution-adjusted Tumor Pathophysiology:. 2013; : 47 doi: 10.1007/978-94-007-6866-6_5
|
80 |
Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha. Prostate cancer: the need for biomarkers and new therapeutic targets. Journal of Zhejiang University SCIENCE B 2014; 15(1): 16 doi: 10.1631/jzus.B1300106
|
81 |
Maria Cecilia Oliveira-Nunes, Glaucia Julião, Aline Menezes, Fernanda Mariath, John A. Hanover, Joseph Albert Medeiros Evaristo, Fábio César Sousa Nogueira, Wagner Barbosa Dias, Denise de Abreu Pereira, Katia Carneiro. O-GlcNAcylation protein disruption by Thiamet G promotes changes on the GBM U87-MG cells secretome molecular signature. Clinical Proteomics 2021; 18(1) doi: 10.1186/s12014-021-09317-x
|
82 |
Petros D. Grivas, Diane M. Robins, Maha Hussain. Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer. Critical Reviews in Oncology/Hematology 2013; 85(1): 82 doi: 10.1016/j.critrevonc.2012.05.003
|
83 |
Julia Matuszewska, Adrianna Krawiec, Artur Radziemski, Paweł Uruski, Andrzej Tykarski, Justyna Mikuła-Pietrasik, Krzysztof Książek. Alterations of receptors and insulin-like growth factor binding proteins in senescent cells. European Journal of Cell Biology 2024; 103(3): 151438 doi: 10.1016/j.ejcb.2024.151438
|
84 |
Afaf D. Abd El-Magid, Omnia M. AbdEl-Hamid, M. A. Younes. The Biochemical Effects of Silver Nanoparticles and Spirulina Extract on Experimentally Induced Prostatic Cancer in Rats. Biological Trace Element Research 2023; 201(4): 1935 doi: 10.1007/s12011-022-03298-0
|
85 |
Ishani Paul, Alankar Roy, Sujay Ray. Molecular Design of Novel Inhibitor by Targeting IL‐6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold‐Hopping Techniques: A Dual Therapeutic Strategy for COVID‐19 and Cancer. Chemistry & Biodiversity 2023; 20(12) doi: 10.1002/cbdv.202300806
|
86 |
Cosmin-Victor Ene, Bogdan Geavlete, Cristian Mares, Ilinca Nicolae, Corina Daniela Ene. Dynamic Soluble IL-6R/Soluble gp130 Ratio as a Potential Indicator for the Prostate Malignancy Phenotype—A Multicenter Case–Control Study. Journal of Personalized Medicine 2024; 14(10): 1037 doi: 10.3390/jpm14101037
|
87 |
Gabriela Vilema-Enríquez, Aurora Arroyo, Marcelo Grijalva, Ricardo Israel Amador-Zafra, Javier Camacho, Alexandr V. Bazhin. Molecular and Cellular Effects of Hydrogen Peroxide on Human Lung Cancer Cells: Potential Therapeutic Implications. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/1908164
|
88 |
Huldani Huldani, Sana Abdul-Jabbar Ali, F. Al-dolaimy, Ahmed Hjazi, Nikolenko Denis Andreevich, Khulood H. Oudaha, Abbas F. Almulla, Ali Alsaalamy, Shamam Kareem Oudah, Yasser Fakri Mustafa. The potential role of interleukins and interferons in ovarian cancer. Cytokine 2023; 171: 156379 doi: 10.1016/j.cyto.2023.156379
|
89 |
Xiangrong Cui, Jianping Liu, Lu Bai, Jie Tian, Jing Zhu. Interleukin‐6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3. Cancer Science 2014; 105(1): 64 doi: 10.1111/cas.12313
|
90 |
Lu Miao, Aaron K. Holley, Yanming Zhao, William H. St. Clair, Daret K. St. Clair. Redox-Mediated and Ionizing-Radiation-Induced Inflammatory Mediators in Prostate Cancer Development and Treatment. Antioxidants & Redox Signaling 2014; 20(9): 1481 doi: 10.1089/ars.2013.5637
|
91 |
Jean-François Rossi, Zhao-Yang Lu, Michel Jourdan, Bernard Klein. Interleukin-6 as a Therapeutic Target. Clinical Cancer Research 2015; 21(6): 1248 doi: 10.1158/1078-0432.CCR-14-2291
|
92 |
Que-Huong Tran, Hoang-Nhi Cao, Dac-Nhan Nguyen, Thi-Thuy-Nga Tran, Minh-Tri Le, Quoc-Thai Nguyen, Van-Thanh Tran, Viet-Hung Tran, Khac-Minh Thai. Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitors. Journal of Biomolecular Structure and Dynamics 2023; 41(23): 14003 doi: 10.1080/07391102.2023.2193990
|